Platelet reactivity influences clot structure as assessed by fractal analysis of viscoelastic properties

Platelets
Rebecca B M KnowlesPhillip A Evans

Abstract

Despite the interwoven nature of platelet activation and the coagulation system in thrombosis, few studies relate both analysis of protein and cellular parts of coagulation in the same population. In the present study, we use matched ex vivo samples to determine the influences of standard antiplatelet therapies on platelet function and use advanced rheological analyses to assess clot formation. Healthy volunteers were recruited following fully informed consent then treated for 7 days with single antiplatelet therapy of aspirin (75 mg) or prasugrel (10 mg) or with dual antiplatelet therapy (DAPT) using aspirin (75 mg) plus prasugrel (10 mg) or aspirin (75 mg) plus ticagrelor (90 mg). Blood samples were taken at day 0 before treatment and at day 7 following treatment. We found that aspirin plus prasugrel or aspirin plus ticagrelor inhibited platelet responses to multiple agonists and reduced P-selectin expression. Significant platelet inhibition was coupled with a reduction in fractal dimension corresponding to reductions in mean relative mass both for aspirin plus prasugrel (-35 ± 16% change, p = 0.04) and for aspirin plus ticagrelor (-45 ± 14% change, p = 0.04). Aspirin alone had no effect upon measures of clot structure, where...Continue Reading

References

Jan 1, 1994·The American Journal of the Medical Sciences·P E GreilichR M Dent
Nov 7, 1998·Biochimica Et Biophysica Acta·R F ZwaalE M Bevers
Jan 5, 1999·Haemophilia : the Official Journal of the World Federation of Hemophilia·H R RobertsM Hoffman
May 23, 2000·Lancet·B Dahlbäck
Jul 20, 2001·Annals of the New York Academy of Sciences·S HeA H Henschen-Edman
Sep 17, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·Dougald M MonroeHarold R Roberts
Mar 19, 2003·The Journal of Biological Chemistry·Jean-Philippe ColletJohn W Weisel
Nov 1, 2003·Thrombosis Research·J R Vane, R M Botting
Jun 19, 2004·Blood·Sanford J Shattil, Peter J Newman
Jun 26, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Eleanor M ScottPeter J Grant
Dec 2, 2004·Biophysical Chemistry·John W Weisel
Apr 27, 2005·Seminars in Thrombosis and Hemostasis·Béatrice HechlerChristian Gachet
May 17, 2005·Journal of Thrombosis and Haemostasis : JTH·A D MichelsonUNKNOWN Working Group on Aspirin Resistance
Dec 13, 2006·Circulation Research·Stefan Offermanns
Dec 14, 2007·The New England Journal of Medicine·Giovanni Davì, Carlo Patrono
Nov 7, 2009·Blood·Robert A S Ariëns
Nov 6, 2012·The New England Journal of Medicine·Jean-Philippe ColletUNKNOWN ARCTIC Investigators
Aug 27, 2013·PloS One·Søs Neergaard-PetersenErik Lerkevang Grove
Oct 11, 2014·British Journal of Haematology·Matthew J LawrencePhillip A Evans
Aug 22, 2015·Thrombosis and Haemostasis·Nia Anne DaviesPhillip Adrian Evans

❮ Previous
Next ❯

Citations

Jan 24, 2021·Cardiovascular Research·Wern Yew DingGregory Y H Lip

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.